Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride: Comparison with Tc-99m-ECD

NuklearMedizin

Volumn 38, Issue 3, 1999, Pages 80-84

  Barthel, Henryk ^a   Kampfer I ^b   Seese, A ^b   Dannenberg, C ^b   Kluge, R ^b   Burchert, W ^b   Knapp, W H ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

Cobalt chloride; In vitro stability; Methylene blue; Tc 99m ECD; Tc 99m HMPAO

Indexed keywords

COBALT CHLORIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHYLENE BLUE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; DRUG STABILITY; FEMALE; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEURORADIOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0345320354     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632196     Document Type: Article

References (27)

1. Amersham Healthcare. Functional brain imaging with Cetetec and SPECT - a user's guide. 1994.
2. Anderson AR. Tc-99m-Hexamethylene-propyleneamine oxime (Tc-99m-HMPAO): basic kinetic studies of a tracer of cerebral blood flow. Cerebrovasc Brain Metab Rev 1989; 1: 288-318.
3. Ballinger JR, Gulenchyn KY. Alternative formulations of techntium-99m HMPAO. Int J Radiat Appl Instrum (A) 1991; 42: 315-6.
4. Billinghurst MW, Abrams DN, Lawson MS. Stabilization of [99m]HMPAO - 1. Ethanolic preparation. Int J Radiat Appl Instrum (A) 1991; 42: 607-12.
5. Ceretec package insert. Amersham International plc, 1989.
6. Costa DC, Ell PJ, Cullum ID et al. The in vivo distribution of 99mTc-HMPAO in normal man. Nucl Med Commun 1986; 7: 647-58.
7. Ding HY, Yeh SJ, Yang CC et al. Study of decomposition kinetics od Tc-99m-d,l-HMPAO complex in aqueous solution. Appl Radiat Isot 1997; 48(3): 311-7.
8. Ell PJ, Cullum I, Costa DC et al. A new regional cerebral blood flow mapping with Tc-99m-labelled compound. Lancet 1985; II: 50-1.
9. Gartshore G, Bannan P et al. Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia. Eur J Nucl Med 1994; 21: 913-23.
10. Hung JC, Corlija M, Volkert WA et al. Kinetic analysis of technetium-99m d,l-HM-PAO decomposition in aqueous media. J Nucl Med 1988; 29: 1568-76.
11. Hung JC, Volkert WA, Holmes RA. Stabilization of techntium-99m-D,L-hexamethyl-propyleneamine oxime (99mTc-D,L-HMPAO) using gentisic acid. Int J Radiat Appl Instrum (B) 1989; 16: 675-80.
12. Iwamoto J, Yoshinaga M, Yang SP et al. Methylene blue inhibits hypoxic cerebral vasodilation in awake sheep. J Appl Physiol 1992; 73(6): 2226-32.
13. Lang J, Barbarics E, Lazar J et al. Effects of labeling conditions and formulations of kit on in vitro stability of 99mTc-d,l-HM-PAO. Eur J Nucl Med 1989; 15: 424.
14. Lang J, Barbarics E, Lazar J et al. A novel d,l-HM-PAO kit formulation providing high in vitro lipophilic complex stability. Eur J Nucl Med 1990; 16: 541.
15. Léveillé J, Demonceau G, Walovitch RC. Intrasubject comparison between Technetium-99m-ECD and Technetium-99m-HMPAO in healthy human subjects. J Nucl Med 1992; 33: 480-4.
16. Lucignani G, Rossetti C, Ferrario P et al. In vivo metabolism and kinetics of (99mTc) HM-PAO. Eur J Nucl Med 1990; 16: 249-55.
17. Man'gera KO, Vanbilloen HP et al. Stabilisation of high-activity Tc-99m-d,l-HMPAO preparations with cobalt chloride and their biological behaviour. Eur J Nucl Med 1995; 22: 1163-72.
18. Matsuda H, Li YM et al. Comparative Spect study of stroke using Tc-99m-ECD, I-123-IMP, and Tc-99m-HMPAO. Clin Nucl Med 1993; 18(9): 754-8.
19. Moretti JL, Defer G Cinotti L et al. Comparative tomoscintigraphic study of strokes using ECD Tc-99m, HMPAO Tc-99m and IMP I-123. preliminary results (abstract). Eur J Nucl Med 1988; 14 (5/6): 311.
20. Neirinckx R, Canning L, Piper I et al. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987; 28: 191-202.
21. Neurolite pack leaflet. DuPont Pharma GmbH, 1993.
22. Payne JK, Trivedi MH, Devous MD. Comparison of Technetium-99m-HMPAO and Xenon-133 measurements of regional cerebral blood flow by SPECT. J Nucl Med 1996; 37: 1735-40.
23. Pupi A, Castagnoli A, De Cristofaro MT et al. Quantitative comparison between Tc-99m-HMPAO and Tc-99m-ECD: measurement of arterial input and brain retention. Eur J Nucl Med 1994; 21: 124-30.
24. Sampson CB, Solanki C. Stabilisation of Tc-99m examtazime using ethanol and storage at a low temperature. Eur J Nucl Med 1991; 18: 532.
25. Sharp PF, Schmith FW, Gummell HG et al. Technetuim-99m HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986; 27: 171-7.
26. Solanki C, Li DJ, Wong A et al. Stabilization and multidose use of examtazime for cerebral perfusion studies. Nucl Med Commun 1994; 15: 718-22.
27. Weisner PS, Bower GR, Dollimore LA et al. A method for stabilizing technetium-99m exametazime prepared from a commercial kit. Eur J Nucl Med 1993; 20: 661-6.